{"pmid":32464105,"title":"Sudden severe thrombocytopenia in a patient in the recovery stage of COVID-19.","text":["Sudden severe thrombocytopenia in a patient in the recovery stage of COVID-19.","Lancet Haematol","Chen, Wanxin","Yang, Bohan","Li, Ziping","Wang, Ping","Chen, Yan","Zhou, Hao","32464105"],"journal":"Lancet Haematol","authors":["Chen, Wanxin","Yang, Bohan","Li, Ziping","Wang, Ping","Chen, Yan","Zhou, Hao"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32464105","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/S2352-3026(20)30175-7","topics":["Case Report"],"weight":1,"_version_":1668079521445707776,"score":9.490897,"similar":[{"pmid":32342677,"title":"Severe Thrombocytopenia in a Patient with COVID-19.","text":["Severe Thrombocytopenia in a Patient with COVID-19.","Coronavirus disease 2019 (COVID-19) outbreak is spreading rapidly all over the world, being a major threat to public health. Since clinical feature of COVID-19 has not been fully evaluated yet, empirical antibacterial agents are frequently combined for the treatment of COVID-19 in addition to antiviral agents, concerning co-existing bacterial pathogens. We experienced a case of severe thrombocytopenia with epistaxis and petechiae, while treating a COVID-19 patient with ceftriaxone, levofloxacin, and lopinavir/ritonavir. The platelet count decreased to 2,000/mm(3) and recovered after discontinuation of the three suspected drugs. In treating a potentially fatal emerging infectious disease, empirical and/or experimental approach would be unavoidable. However, the present case suggests that the possibility of adverse effects caused by polypharmacy should also be carefully considered.","Infect Chemother","Nham, Eliel","Ko, Jae Hoon","Jeong, Byeong Ho","Huh, Kyungmin","Cho, Sun Young","Kang, Cheol In","Chung, Doo Ryeon","Peck, Kyong Ran","32342677"],"abstract":["Coronavirus disease 2019 (COVID-19) outbreak is spreading rapidly all over the world, being a major threat to public health. Since clinical feature of COVID-19 has not been fully evaluated yet, empirical antibacterial agents are frequently combined for the treatment of COVID-19 in addition to antiviral agents, concerning co-existing bacterial pathogens. We experienced a case of severe thrombocytopenia with epistaxis and petechiae, while treating a COVID-19 patient with ceftriaxone, levofloxacin, and lopinavir/ritonavir. The platelet count decreased to 2,000/mm(3) and recovered after discontinuation of the three suspected drugs. In treating a potentially fatal emerging infectious disease, empirical and/or experimental approach would be unavoidable. However, the present case suggests that the possibility of adverse effects caused by polypharmacy should also be carefully considered."],"journal":"Infect Chemother","authors":["Nham, Eliel","Ko, Jae Hoon","Jeong, Byeong Ho","Huh, Kyungmin","Cho, Sun Young","Kang, Cheol In","Chung, Doo Ryeon","Peck, Kyong Ran"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32342677","source":"PubMed","week":"202018|Apr 27 - May 03","keywords":["covid-19","ceftriaxone, levofloxacin","lopinavir/ritonavir","thrombocytopenia"],"locations":["Thrombocytopenia"],"e_drugs":["Ceftriaxone","lopinavir-ritonavir drug combination","Levofloxacin"],"topics":["Case Report"],"weight":1,"_version_":1666138495809224708,"score":45.589993},{"pmid":32483524,"pmcid":"PMC7255984","title":"Isolated severe thrombocytopenia in a patient with COVID-19: A case report.","text":["Isolated severe thrombocytopenia in a patient with COVID-19: A case report.","COVID-19 is known to cause serious respiratory symptoms and involvement of other body systems such as hematopoietic, neurological and the immune system. In this report, we described a case of a COVID-19 patient who presented with no pulmonary involvement but severe thrombocytopenia. She suffered from headache and malaise with no respiratory symptoms, fever or chills. Chest radiological imaging was unremarkable but, the laboratory results showed significant thrombocytopenia associated with relatively decreased lymphocytes. Based on her high-risk work environment, a reverse transcription polymerase chain reaction (RT-PCR) test was performed and SARS-CoV-2 RNA was detected in the nasopharyngeal swab. Complete blood count (CBC) of patient was re-checked during admission and platelet count showed rising trend up to normal levels. A narrow diagnostic approach where only febrile patients with pulmonary symptoms are evaluated for a COVID-19 diagnosis will result in many missed diagnoses; so it is important that physicians are familiar with atypical and rare presentations of COVID-19, such as isolated thrombocytopenia.","IDCases","Sadr, Sara","SeyedAlinaghi, SeyedAhmad","Ghiasvand, Fereshteh","Hassan Nezhad, Malihe","Javadian, Nina","Hossienzade, Roghieh","Jafari, Fatemeh","32483524"],"abstract":["COVID-19 is known to cause serious respiratory symptoms and involvement of other body systems such as hematopoietic, neurological and the immune system. In this report, we described a case of a COVID-19 patient who presented with no pulmonary involvement but severe thrombocytopenia. She suffered from headache and malaise with no respiratory symptoms, fever or chills. Chest radiological imaging was unremarkable but, the laboratory results showed significant thrombocytopenia associated with relatively decreased lymphocytes. Based on her high-risk work environment, a reverse transcription polymerase chain reaction (RT-PCR) test was performed and SARS-CoV-2 RNA was detected in the nasopharyngeal swab. Complete blood count (CBC) of patient was re-checked during admission and platelet count showed rising trend up to normal levels. A narrow diagnostic approach where only febrile patients with pulmonary symptoms are evaluated for a COVID-19 diagnosis will result in many missed diagnoses; so it is important that physicians are familiar with atypical and rare presentations of COVID-19, such as isolated thrombocytopenia."],"journal":"IDCases","authors":["Sadr, Sara","SeyedAlinaghi, SeyedAhmad","Ghiasvand, Fereshteh","Hassan Nezhad, Malihe","Javadian, Nina","Hossienzade, Roghieh","Jafari, Fatemeh"],"date":"2020-06-03T11:00:00Z","year":2020,"_id":"32483524","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.idcr.2020.e00820","keywords":["coronavirus disease 2019 (covid-19)","lymphopenia","severe acute respiratory syndrome coronavirus 2 (sars-cov-2)","thrombocytopenia"],"topics":["Case Report"],"weight":1,"_version_":1668704334431387648,"score":40.617626},{"pmid":32405457,"pmcid":"PMC7219359","title":"Cardiac injury, Arrhythmia and Sudden death in a COVID-19 patient.","text":["Cardiac injury, Arrhythmia and Sudden death in a COVID-19 patient.","HeartRhythm Case Rep","Beri, Abhimanyu","Kotak, Kamal","32405457"],"journal":"HeartRhythm Case Rep","authors":["Beri, Abhimanyu","Kotak, Kamal"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32405457","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.hrcr.2020.05.001","keywords":["covid-19","cardiac arrest","j-point elevation","myocardial infarction","myocarditis","sars coronavirus-2","st-elevation","sudden death","arrhythmia"],"topics":["Case Report"],"weight":1,"_version_":1666802845542776832,"score":40.199917}]}